Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Parmax Pharma Ltd - 540359 - Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015 For Half Year Ended On 30Th September, 2019

 Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby certify that all activities in relation to both physical and electronic share transfer facility are maintained during the period of 1st April 2019 to 30th September, 2019 (both days inclusive) by the Company's Registrar and Share Transfer Agent, i.e. M/s Purva Sharegistry India Pvt. Ltd.. having its Office at Unit no. 9, Shiv Shakti Ind. Estt. J.R. Boricha Marg, Lower Parel (E), Mumbai 400 011. Further, we confirm that M/s Purva Sharegistry India Pvt. Ltd. is registered as Permanent Category- I '' Registrar and Transfer Agent with the Securities and Exchange Board of India (SEBI Registration no. INR000001112).
10-10-2019
Bigul

Parmax Pharma Ltd - 540359 - Reg. 34 (1) Annual Report

 In continuation of our Corporate Announcement dated 7th September,2019 and pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations)'', please find attached soft copy of the Annual Report for the Financial Year 2018-19. Re-submission of annual report is required because earlier submitted annual report was incomplete in respect of 'Note on Financial Statement' (Specifically note nos. 9 to 19). Further we assure that except stated reason there is no any other reason for this re-submission.
07-10-2019
Bigul

Parmax Pharma Ltd - 540359 - Statement Of Investor Complaints For The Quarter Ended September 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- YASH J VORADesignation :- Company Secretary and Compliance Officer
04-10-2019
Bigul

Parmax Pharma Ltd - 540359 - Closure of Trading Window

 This is to inform you that under the securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and as per the Code of Practices and Procedures and Code of Conduct to Regulate, Monitor and Report Trading in Securities, and the clarification provided vide BSE Circular Ref. No. LIST/COMP/01/2019-20 dated 2ndApril, 2019; the trading window for dealing in securities of the Company shall remain closed with immediate effect till 48 hours after the declaration of financial results for the Quarter ended 30th September, 2019. The date of announcement of the unaudited financial results for the second quarter ending 30th September, 2019 shall be announced in due course
01-10-2019
Bigul

Parmax Pharma Ltd - 540359 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Parmax Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
30-09-2019
Bigul

Parmax Pharma Ltd - 540359 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Voting results and Scrutinizer's report of 25th Annual General Meeting of the Company.
30-09-2019
Bigul

Parmax Pharma Ltd - 540359 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 Proceedings of the 25th Annual General Meeting of the Company held on 27th September, 2019
27-09-2019
Bigul

Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In terms of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached a copy of the advertisement published in Financial Express dt. 9th September, 2019 intimating that the Annual General Meeting of the Company is scheduled to be convened on Friday, the 27th day of September, 2019 and providing of e-voting facility to all members through platform of CDSL.
10-09-2019
Bigul

Parmax Pharma Ltd - 540359 - Reg. 34 (1) Annual Report

 Pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations)'', please find attached soft copy of the Annual Report for the Financial Year 2018-19 along with Notice for the 25th Annual General Meeting of members of Parmax Pharma Limited to be held on Friday, 27th September, 2019 at 1.00 p.m. at Plot No. 20, Survey No. 52, Rajkot-Gondal National Highway No. 27, Hadamtala, Rajkot-360311
07-09-2019
Bigul

Parmax Pharma Ltd - 540359 - Register Of Members And Share Transfer Books Of The Company Will Remain Closed From Saturday, 21St Day Of September, 2019 To Friday, 27Th Day Of September, 2019 (Both Days Inclusive) For The Purpose Of Annual General Meeting.

 This is to inform you that Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, Annual General Meeting of the Company is scheduled to be held on Friday, the 27th September, 2019 and the Register of Members and Share Transfer Books of the Company will remain closed from Saturday, 21st day of September, 2019 to Friday, 27th day of September, 2019 (both days inclusive) for the purpose of Annual General Meeting.
27-08-2019
Next Page
Close

Let's Open Free Demat Account